Medrol, Methylprednisolone News

Doctors are still injecting a steroid made by Bristol-Myers Squibb Co. in a way the company warns they shouldn't, following reports that patients have died or become paralyzed after receiving steroidal shots.

An 85-year-old man is admitted for evaluation of multiple papules, plaques, and subcutaneous nodules on his face, trunk, and extremities.

Advantages for men with metastatic hormone-refractory prostate cancer who are no longer eligible for docetaxel therapy Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.

In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" , the German Institute for Quality and Efficiency in Health Care examined whether abiraterone offers an added benefit compared with the present standard therapy.

Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.